Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) EPS (diluted)
Cardinal Health, Inc.'s EPS (diluted) for fiscal 2026 was $7.23, up 12.1% from $6.45 in fiscal 2025. Over the past ten years it has ranged from −$12.61 (fiscal 2020) to $7.23 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 4 consecutive fiscal years. Cardinal Health, Inc. ranks 3rd of 10 Medical Distribution companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $7.23 | 12.09% |
| FY2025 | $6.45 | 86.96% |
| FY2024 | $3.45 | 245.00% |
| FY2023 | $1.00 | — |
| FY2022 | −$3.35 | — |
| FY2021 | $2.08 | — |
| FY2020 | −$12.61 | — |
| FY2019 | $4.53 | 459.26% |
| FY2018 | $0.81 | (79.90%) |
| FY2017 | $4.03 | (6.71%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $1.69 | 0.00% |
| Mar 2026 | $1.69 | (14.21%) |
| Dec 2025 | $1.97 | 4.79% |
| Sep 2025 | $1.88 | 88.00% |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| MCK McKesson Corporation compare | $37.37 |
| COR Cencora, Inc. compare | $13.46 |
| CAH Cardinal Health, Inc. | $7.23 |
| HSIC Henry Schein, Inc. compare | $3.43 |
| AHG Akso Health Group Sponsored ADR compare | −$0.55 |
| COSM Cosmos Health Inc. compare | −$0.64 |
| FOCL FocalTherics compare | −$1.03 |
| ACH Accendra Health, Inc. compare | −$3.91 |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CAH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement